Dr. Alsayed Abdehay is a Consultant Interventional Radiologist at King Faisal Hospital, Rwanda, with extensive expertise in minimally invasive, image-guided procedures. He is internationally trained and holds a Doctor of Medicine in Vascular and Interventional Radiology from Cairo University, where he also served as a lecturer in interventional radiology. Dr. Abdehay brings specialized skills in advanced image-guided diagnostics and therapeutic procedures, including vascular interventions, interventional spine procedures, and a wide range of non-vascular treatments. His approach focuses on precision, reduced patient recovery times, and enhancing overall outcomes through minimally invasive techniques. In addition to his clinical role at KFH, Dr. Abdehay serves as the Program Director and Coordinator of the Rwanda Interventional Radiology Fellowship Program under the Rwanda Interventional Radiology Initiative (RIRI). Through this role, he is actively shaping the future of interventional radiology in Rwanda by mentoring and training the next generation of radiologists. His dual focus on high-impact clinical care and capacity building makes him a key figure in the advancement of interventional radiology both at King Faisal Hospital and nationally.

Dukundane Damas, MD, MMed, is a Medical Oncologist and Consultant Physician with more than ten years of experience in cancer care and internal medicine. He is licensed by the Rwanda Medical and Dental Council (Registration No. 1373) to practice both Internal Medicine and Medical Oncology. His clinical work focuses on the management of solid tumors—including breast, lung, gastrointestinal, and genitourinary cancers—along with early detection, prevention, and risk‑based screening. He is committed to patient education, advocacy, and shared decision‑making, and he integrates evidence‑based treatment, precision oncology, and supportive care into his practice.

Dr. Damas completed his medical degree at the National University of Rwanda (2010) and his Master of Medicine in Internal Medicine at the University of Rwanda (2016). He trained in Medical Oncology at Tata Memorial Hospital in Mumbai (2018) and later pursued advanced training in diagnostics and therapeutics for solid malignancies at Cliniques universitaires Saint‑Luc in Brussels (2025).

He has held several leadership roles, including serving as Head of Internal Medicine at King Faisal Hospital Rwanda (2020–2024) and President of the Rwanda College of Physicians (2022–2024). He currently leads the Oncology Unit at King Faisal Hospital, working closely with multidisciplinary teams to strengthen cancer services and improve patient pathways.

Dr. Damas is also a senior faculty member at the African Health Sciences University, where he teaches in the Department of Internal Medicine and contributes to curriculum development.

Alongside his clinical and academic responsibilities, he mentors trainees, participates in multidisciplinary tumor boards, and supports initiatives aimed at expanding access to quality oncology care in resource‑limited settings. His professional interests include research for quality improvement, patient‑centered cancer advocacy, and participation in clinical trials that broaden access to innovative therapies.

Dr. Apollo MUGABO, MMed of Medical Oncology from NCI Cairo University-Egypt, Consultant of Medical Oncology at KFH-R. He assesses, diagnoses ,treats and manages patients with Cancer in both solid Tumors and Hematological Malignancies.

Dr. Achille Manirakiza is a Consultant Clinical Oncologist and Head of the Oncology Unit at King Faisal Hospital, Kigali. He is actively involved in both clinical care and research, with a strong focus on improving cancer outcomes in low-resource settings. His areas of expertise span clinical and radiation oncology, with special emphasis on the treatment of central nervous system, head and neck, breast, gastrointestinal, genito-urinary, skin, and sarcoma malignancies.

His research interests include gynecological malignancies and cancer genetics, particularly prostate cancer genetics and treatment outcomes in Rwanda. He is currently leading multiple funded studies on castrate-resistant prostate cancer and the genetic basis of prostate cancer in the Rwandan population.

Dr. Manirakiza is a recipient of numerous prestigious grants and fellowships, including the UICC Technical Fellowship, Dana Farber Cancer Institute’s GLOBE Program (2016), the African Cancer Leadership Institute (2017), and the Massachusetts General Hospital POETIC grant (2018).

Education:

• Master of Medicine in Clinical Oncology – Muhimbili University of Health and Allied Sciences (2015–2018)
• Bachelor of Medicine, Bachelor of Surgery (MBBS) – National University of Rwanda (2008–2013)

His dedication to cancer genetics, treatment equity, and oncological education continues to drive advancements in cancer care both locally and regionally.